financetom
Business
financetom
/
Business
/
US judge signals Musk's xAI may lose lawsuit accusing Altman's OpenAI of stealing trade secrets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US judge signals Musk's xAI may lose lawsuit accusing Altman's OpenAI of stealing trade secrets
Mar 11, 2026 2:25 AM

Jan 30 (Reuters) - A federal judge signaled on Friday she may dismiss a lawsuit by Elon Musk's artificial intelligence startup xAI accusing Sam Altman's rival OpenAI of stealing trade secrets to gain an unfair advantage in developing AI technology.

U.S. ‌District Judge Rita Lin in San Francisco said her "tentative view" is to grant OpenAI's motion to ​dismiss xAI's lawsuit, pending oral arguments on February 3. She also said ‍tentatively that xAI could amend its claims if she ⁠dismissed its case.

Lawyers ⁠for xAI and OpenAI did not immediately respond to requests for comment.

Musk's startup sued OpenAI ‌in September, accusing it of hiring xAI ​employees away to obtain confidential information related to the AI chatbot Grok.

OpenAI, known for its ChatGPT chatbot, countered by accusing Musk ⁠of conducting a "campaign to harass ‍a competitor ​with unfounded legal claims" because xAI could not keep up with ChatGPT.

In a four-page filing outlining her thoughts, Lin said Musk's startup ‍did not plausibly allege that OpenAI acquired or encouraged the theft of trade secrets, despite allegations that some former xAI employees downloaded source code before leaving.

Lin also said it was not plausible to infer from xAI's complaint that OpenAI used xAI's trade secrets, or the former xAI ​employees used ‍them on the job after joining OpenAI.

The judge may also dismiss an unfair competition claim, saying xAI's poaching allegations "all focus on ​poaching in service of acquiring xAI's trade secrets and do not identify any other reason why the hiring of those employees was anticompetitive."

Lin asked xAI and OpenAI to address her tentative reasoning at the hearing.

The lawsuit is part of a broader legal battle between Musk and OpenAI, which he co-founded and is also ​suing over its conversion to a for-profit company.

Musk, the world's richest person, is seeking as much as $134.5 billion in damages from OpenAI and Microsoft in that case. Jury selection is scheduled ‍for April 27.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dow and X-energy submit for construction permit for nuclear project in Texas
Dow and X-energy submit for construction permit for nuclear project in Texas
Mar 31, 2025
March 31 (Reuters) - Chemical firm Dow and X-energy Reactor Company have submitted a construction permit application to the Nuclear Regulatory Commission (NRC) for a proposed nuclear project in Seadrift, Texas, the companies said on Monday. WHY IS IT IMPORTANT The U.S. nuclear industry, which has faced expansion challenges in recent decades, is witnessing a surge in demand on the...
Cannae to Allot $460 Million From Dun & Bradstreet Sale to Stock Buybacks, Dividends, Debt
Cannae to Allot $460 Million From Dun & Bradstreet Sale to Stock Buybacks, Dividends, Debt
Mar 31, 2025
09:11 AM EDT, 03/31/2025 (MT Newswires) -- Cannae Holdings ( CNNE ) said Monday that it plans to use at least $460 million from the proceeds of the sale of its investment, Dun & Bradstreet ( DNB ) , to buy back shares of its common stock, as well as to pay future dividends and retire existing debt. Cannae said...
Dow and X-energy submit for construction permit for nuclear project in Texas
Dow and X-energy submit for construction permit for nuclear project in Texas
Mar 31, 2025
(Reuters) - Chemical firm Dow and X-energy Reactor Company have submitted a construction permit application to the Nuclear Regulatory Commission (NRC) for a proposed nuclear project in Seadrift, Texas, the companies said on Monday. WHY IS IT IMPORTANT The U.S. nuclear industry, which has faced expansion challenges in recent decades, is witnessing a surge in demand on the back of...
Alphabet's Isomorphic Labs Unit Raises $600 Million for AI-Based Drug Development
Alphabet's Isomorphic Labs Unit Raises $600 Million for AI-Based Drug Development
Mar 31, 2025
09:09 AM EDT, 03/31/2025 (MT Newswires) -- Alphabet's (GOOG, GOOGL) artificial intelligence-based drug discovery unit Isomorphic Labs said Monday it raised $600 million in its first external funding round to develop its AI drug design engine and support drug candidates into clinical testing. The investment, led by Thrive Capital with participation from GV and Alphabet, is expected to support AI...
Copyright 2023-2026 - www.financetom.com All Rights Reserved